Financial report interval: 2025.07.01 - 2025.12.31
Preview: SKB BIO(06990) predict that the Revenue is 1.232 B (+110.4%), Beat estimate;the EBIT is -323.1 M (+44.83%), Beat estimate;the EPS is -1.29 (+56.65%), Beat estimate.